References
  1. Alanazi, Alanazi N AI, Almoosa Z, Iqbal Z. First report of coexistence of sickle cell disease and neurofibromatosis Type 1 in a Saudi patient with family history of neurofibromatosis Type 1. 2019.
  2. Vanka P, Tejavath R, Chandra N, Swaroopa D, Subbalaxmi M, Yedla D. A rare case report of coexistent neurofibromatosis type 1 with sickle cell beta-plus thalassaemia. Journal of Clinical and Scientific Research. 2020;9(45).
  3. CrÈange A, Zeller J, Rostaing-Rigattieri S, et al. Neurological complications of neurofibromatosis type 1 in adulthood. Brain. 2021;122(3):473-481.
  4. Segal L, Discepola M. Idiopathic intracranial hypertension and sickle cell disease: two case reports. Can J Ophthalmol. 2005 Dec;40(6):764-7. doi: 10.1016/S0008-4182(05)80097-3. PMID: 16391644.
  5. Henry M, Driscoll MC, Miller M, Chang T, Minniti CP. Pseudotumor Cerebri in Children With Sickle Cell Disease: A Case Series. 2004;113(3):e265-e269.
  6. Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, Macedo TA, Stanson A. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg. 2007 Sep;46(3):475-484. doi: 10.1016/j.jvs.2007.03.055. Epub 2007 Jul 30. PMID: 17681709.
  7. Booth C, Preston R, Clark G, Reidy J. Management of renal vascular disease in neurofibromatosis type 1 and the role of percutaneous transluminal angioplasty. Nephrology Dialysis Transplantation.  2002;17(7):1235-1240.
  8. Serafini NB SC, Vinhas AS, Godinho MB. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient. 2017;92(6):870-873.
  9. Usmani A, Machado RF. Vascular complications of sickle cell disease. Clin Hemorheol Microcirc . 2018;68(2-3):205-221. doi:10.3233/CH-189008
  10. Jutant E-M, Girerd B, JaÔs X, et al. Pulmonary hypertension associated with neurofibromatosis type 1. 2018;27.
  11. Benneh-Akwasi Kuma A O-AAM, Sey F, Olayemi E, Nouraie M, et al. Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana. 2018;13(1).
  12. Mercille G, Ospina LH. Pediatric Idiopathic Intracranial Hypertension. 2007;28(11):e77-e86.
  13. Rahimi Z, Parsian A. Sickle cell disease and venous thromboembolism. Mediterr J Hematol Infect Dis. 2011;3(1):e2011024. doi: 10.4084/MJHID.2011.024. Epub 2011 May 24. PMID: 21713075; PMCID: PMC3113276.
  14. Terry AR, Jordan JT, Schwamm L, Plotkin SR. Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach. Stroke. 2016 Jan;47(1):60-5. doi: 10.1161/STROKEAHA.115.011406. Epub 2015 Dec 8. PMID: 26645253.
  15. Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño J, Carceller-Benito F. Estenosis del acueducto de Silvio en la neurofibromatosis tipo 1. Presentación de 19 pacientes infantiles [Aqueductal stenosis in the neurofibromatosis type 1. Presentation of 19 infantile patients]. Rev Neurol. 2007 Jul 1-15;45(1):18-21. Spanish. PMID: 17620261.
  16. Rigano P, Pecoraro A, Calvaruso G, Steinberg MH, Iannello S, Maggio A. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians. Am J Hematol. 2013 Nov;88(11):E261-4. doi: 10.1002/ajh.23531. Epub 2013 Aug 30. PMID: 23828131.
  17. Chamouine A ST, Muszlak M, et al. High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte. BMC Pediatr. 2020;20(1):302.